The cardiac cycle consists of two phases; a period where the heart muscle is relaxed, called <u>diastole</u>, and a period of contraction, called <u>systole</u>.
These are then divided into four stages. These are;
1.<u>Ventricular Filling Period (VPF)</u>
2. <u>Isovolumetric Contraction Period (ICP)</u>
3. <u>Ventricular Ejection Period (VEP)</u>
4.<u> Isovolumetric Relaxation Period (IRP)</u>
At rest, cardiac diastole lasts for approximately 0.5 seconds, and cardiac systole lasts approximately 0.3 seconds to complete. However, during exercise, when the heart rate is increased the time period of <u>diastole</u> , especially, is reduced.
College students are not usually the most financially stable and junk food tends to be cheaper than healthy food. Therefore, college students can only afford to eat unhealthy foods. College students can try to find healthy alternatives that are cheap and try saving their money. Always make sure that their is a fruit or at least something healthy in their meal. If your parents want you to decrease your fat intake, a good thing to keep in mind is that eating later at night actually causes you to gain weight more than eating during the day.
Explanation:
Ethical doubts about genetic engineering motivate a view that many philosophers favour: that genetic therapy to eliminate disease and disability is ethically acceptable, given that the risks can be overcome.
But genetic enhancement is ethically problematic. The line between enhancement and therapy is difficult to draw.
Studies show people who are physically attractive are likely to earn more than those considered to have below-average looks. Does this mean “ugliness” is a disability that ought to be corrected by genetic engineering?
Or, similarly, is having a below-average IQ a disability, something that should be subject to change through gene-editing?
Answer:
Explanation:
Advantages of Anticoagulant Therapy
Anticoagulant therapy remains the mainstay of medical therapy for deep venous thrombosis (DVT) because it is non-invasive, it treats most patients (approximately 90%) with no immediate demonstrable physical sequelae of DVT, it has a low risk of complications, and its outcome data demonstrates an improvement in morbidity and mortality. Meta-analyses of randomized trials of unfractionated heparin (UFH) and low-molecular-weight heparin (LMWH) have shown that they are similar, with a 4% risk of recurrent DVT, a 2% risk of pulmonary embolism (PE), and a 3% risk of major bleeding.
